Oral presentation of an abstract from research trials involving the SUCCEED Equine Fecal Blood Test was delivered at the 47th European Veterinary Conference Voorjaarsdagen, April 17-19, 2014, in Amsterdam, The Netherlands. “The effect of parasite burden on faecally excreted albumin” was presented by the principal researcher, Nicola Kerbyson, BVMS, Cert AVP (EM), MRCVS, a PhD student at Glasgow.
The aim of the study was to establish if albumin excreted in a horse’s feces, measured using the SUCCEED Equine Fecal Blood Test, was related to the parasite burden of the horse. The results of the study indicate that parasite burden is associated with the likelihood of being positive for fecal albumin using the SUCCEED fecal occult blood test kit.
The study presented is one of six clinical research trials utilizing the SUCCEED Equine Fecal Blood Test currently in progress, five at the University of Glasgow (Scotland) and the sixth in Ireland. The trials are being conducted under the supervision of Derek Knottenbelt, OBE, BVM&S, DECEIM, MRCVS, and Tim Parkin, PhD, DECVPH, MRCVS. Knottenbelt is Professor of Equine Medicine at the University of Liverpool (UK) and Clinical Consultant at the Weipers Centre Equine Hospital at the University of Glasgow. Parkin is Senior Research Fellow with the School of Veterinary Medicine, University of Glasgow.
Results of these various trials will be presented at a number of different scientific conferences worldwide throughout 2014. This includes presentations at the Australian Veterinary Association Conference in Perth, Australia, May 25-29, a poster presentation at the ACVIM conference in Nashville, Tennessee, June 4-7, and both oral and poster presentations at the Equine Colic Research Symposium hosted by the British Equine Veterinary Association (BEVA) in Dublin, Ireland, July 8-10. Abstracts have also been submitted to the BEVA Congress in September in Birmingham, UK, and to AAEP Convention in December, in Salt Lake City, Utah.
The SUCCEED Equine Fecal Blood Test (FBT) is an equine-specific rapid screen test that aids the veterinarian’s diagnosis of digestive tract conditions in equine patients. The FBT provides practitioners with a quick stall-side screen for pathological conditions of the equine foregut, hindgut or both, that may guide further diagnostic methods and help avoid more costly or invasive procedures. Veterinarians can obtain the SUCCEED FBT through major veterinary supply distributors in the U.S., including Henry Schein Animal Health, Patterson Veterinary, MWI Animal Health, Midwest Veterinary Supply and Animal Health International. For more information, visit www.succeedFBT.com.
The SUCCEED FBT is produced by Freedom Health LLC of Aurora, Ohio. The company is focused on finding, perfecting and delivering superior, innovative products that address real and significant health-related issues for animals and the people who care for them.